<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font6" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font7" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font8" size="9" family="SymbolMT" color="#000000"/>
<text top="42" left="56" width="198" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Breast Cancer Research Vol 8 No 5    Grigoriadis et al.<b>Breast Cancer Research</b></text>
<text top="758" left="56" width="45" height="7" font="font1" id="p1_t2" reading_order_no="102" segment_no="10" tag_type="text">Page 2 of 15</text>
<text top="768" left="56" width="120" height="6" font="font3" id="p1_t3" reading_order_no="103" segment_no="11" tag_type="text">(page number not for citation purposes)<i>et al.</i></text>
<text top="128" left="56" width="64" height="10" font="font4" id="p1_t4" reading_order_no="1" segment_no="2" tag_type="title">Introduction</text>
<text top="140" left="56" width="240" height="9" font="font5" id="p1_t5" reading_order_no="2" segment_no="3" tag_type="text">Breast cancer is a clinically heterogeneous disease and con-<i>(page number not for citation purposes)</i></text>
<text top="152" left="56" width="240" height="9" font="font5" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="text">sists of many different cell types, including normal and reactive<b>Introduction</b></text>
<text top="163" left="56" width="240" height="9" font="font5" id="p1_t7" reading_order_no="4" segment_no="3" tag_type="text">stromal components in addition to the malignant neoplastic</text>
<text top="175" left="56" width="240" height="9" font="font5" id="p1_t8" reading_order_no="5" segment_no="3" tag_type="text">compartment. Moreover, it comprises a series of distinct</text>
<text top="187" left="56" width="241" height="9" font="font5" id="p1_t9" reading_order_no="6" segment_no="3" tag_type="text">malignant tumours that present diverse cellular features with</text>
<text top="199" left="56" width="240" height="9" font="font5" id="p1_t10" reading_order_no="7" segment_no="3" tag_type="text">varying differentiation status, distinct genetic changes,</text>
<text top="210" left="56" width="240" height="9" font="font5" id="p1_t11" reading_order_no="8" segment_no="3" tag_type="text">responses to therapy and outcome [1]. Likewise, the normal</text>
<text top="222" left="56" width="240" height="9" font="font5" id="p1_t12" reading_order_no="9" segment_no="3" tag_type="text">breast is also composed of different parenchymal and stromal</text>
<text top="234" left="56" width="240" height="9" font="font5" id="p1_t13" reading_order_no="10" segment_no="3" tag_type="text">cell types, with the terminal ductal-lobular unit being the most<a href="">ome [1].</a> Likewise, the normal</text>
<text top="246" left="56" width="240" height="9" font="font5" id="p1_t14" reading_order_no="11" segment_no="3" tag_type="text">important feature with regard to neoplasia. The latter is com-</text>
<text top="257" left="56" width="240" height="9" font="font5" id="p1_t15" reading_order_no="12" segment_no="3" tag_type="text">posed of two morphologically recognisable cell types, epithe-</text>
<text top="269" left="56" width="240" height="9" font="font5" id="p1_t16" reading_order_no="13" segment_no="3" tag_type="text">lial cells on the luminal surface and basally located</text>
<text top="281" left="56" width="241" height="9" font="font5" id="p1_t17" reading_order_no="14" segment_no="3" tag_type="text">myoepithelial cells. While typical breast cancers have been</text>
<text top="293" left="56" width="240" height="9" font="font5" id="p1_t18" reading_order_no="15" segment_no="3" tag_type="text">traditionally regarded as exhibiting characteristics akin to lumi-</text>
<text top="304" left="56" width="240" height="9" font="font5" id="p1_t19" reading_order_no="16" segment_no="3" tag_type="text">nal epithelial cells, recent data have shown that some also</text>
<text top="316" left="56" width="240" height="9" font="font5" id="p1_t20" reading_order_no="17" segment_no="3" tag_type="text">exhibit, in part or whole, myoepithelial/basal features [2-4].</text>
<text top="328" left="56" width="240" height="9" font="font5" id="p1_t21" reading_order_no="18" segment_no="3" tag_type="text">Based on the restricted expression of genes representing the</text>
<text top="340" left="56" width="241" height="9" font="font5" id="p1_t22" reading_order_no="19" segment_no="3" tag_type="text">phenotypes of luminal epithelial and basal cells [4], major sub-<a href="">[2-4]</a>.</text>
<text top="351" left="56" width="240" height="9" font="font5" id="p1_t23" reading_order_no="20" segment_no="3" tag_type="text">types of breast cancer have been defined and linked to both</text>
<text top="363" left="56" width="240" height="9" font="font5" id="p1_t24" reading_order_no="21" segment_no="3" tag_type="text">long term survival [5] and their response to therapy [6]. There-<a href=""> [4]</a>, major sub-</text>
<text top="375" left="56" width="240" height="9" font="font5" id="p1_t25" reading_order_no="22" segment_no="3" tag_type="text">fore, detailed characterisation of the normal luminal and</text>
<text top="387" left="56" width="240" height="9" font="font5" id="p1_t26" reading_order_no="23" segment_no="3" tag_type="text">myoepithelial/basal phenotypes is a prerequisite for under-<a href="">ival [5] an</a>d their response to ther<a href="">apy [6]. Ther</a>e-</text>
<text top="398" left="56" width="240" height="9" font="font5" id="p1_t27" reading_order_no="24" segment_no="3" tag_type="text">standing the genetic alterations that occur in breast cancers</text>
<text top="410" left="56" width="240" height="9" font="font5" id="p1_t28" reading_order_no="25" segment_no="3" tag_type="text">and how they may impact on disease progression and</text>
<text top="422" left="56" width="36" height="9" font="font5" id="p1_t29" reading_order_no="26" segment_no="3" tag_type="text">outcome.</text>
<text top="445" left="56" width="240" height="9" font="font5" id="p1_t30" reading_order_no="27" segment_no="7" tag_type="text">The use of solid tissues, as in most previous breast cancer</text>
<text top="457" left="56" width="240" height="9" font="font5" id="p1_t31" reading_order_no="28" segment_no="7" tag_type="text">gene expression analyses, results in greatly enhanced com-</text>
<text top="469" left="56" width="240" height="9" font="font5" id="p1_t32" reading_order_no="29" segment_no="7" tag_type="text">plexity of data because of the widely varying degrees of stro-</text>
<text top="481" left="56" width="241" height="9" font="font5" id="p1_t33" reading_order_no="30" segment_no="7" tag_type="text">mal responses (desmoplasia) and inflammatory infiltrates in</text>
<text top="492" left="56" width="240" height="9" font="font5" id="p1_t34" reading_order_no="31" segment_no="7" tag_type="text">individual tumours. Laser capture microdissection partially</text>
<text top="504" left="56" width="240" height="9" font="font5" id="p1_t35" reading_order_no="32" segment_no="7" tag_type="text">alleviates this problem in respect to tumour samples, but is</text>
<text top="516" left="56" width="240" height="9" font="font5" id="p1_t36" reading_order_no="33" segment_no="7" tag_type="text">unsuited to the large-scale separation of the normal epithelial</text>
<text top="528" left="56" width="240" height="9" font="font5" id="p1_t37" reading_order_no="34" segment_no="7" tag_type="text">cell types in breast because of the close contact between</text>
<text top="539" left="56" width="240" height="9" font="font5" id="p1_t38" reading_order_no="35" segment_no="7" tag_type="text">these cells. Immunomagnetic separation of individual cell</text>
<text top="551" left="56" width="240" height="9" font="font5" id="p1_t39" reading_order_no="36" segment_no="7" tag_type="text">types from normal human breast tissue [7,8] and primary</text>
<text top="563" left="56" width="240" height="9" font="font5" id="p1_t40" reading_order_no="37" segment_no="7" tag_type="text">breast cancers [9] has enabled direct comparisons of normal</text>
<text top="575" left="56" width="240" height="9" font="font5" id="p1_t41" reading_order_no="38" segment_no="7" tag_type="text">epithelial and malignant epithelial cells to be made. Previous<a href="">7,8] and pri</a>mary</text>
<text top="586" left="56" width="240" height="9" font="font5" id="p1_t42" reading_order_no="39" segment_no="7" tag_type="text">proteomic [9,10] and gene expression analyses of such sam-<a href="">rs [9] has en</a>abled direct comparisons of normal</text>
<text top="598" left="56" width="240" height="9" font="font5" id="p1_t43" reading_order_no="40" segment_no="7" tag_type="text">ples [10-13] have established a partial molecular characterisa-</text>
<text top="610" left="56" width="240" height="9" font="font5" id="p1_t44" reading_order_no="41" segment_no="7" tag_type="text">tion of the epithelial compartment in the normal breast and<a href=""> [9,10] and gene</a> expression analyses of such sam-</text>
<text top="622" left="56" width="240" height="9" font="font5" id="p1_t45" reading_order_no="42" segment_no="7" tag_type="text">breast cancer [2], but, due to the limitations of technology<a href="">ples [10-13]</a> have established a partial molecular characterisa-</text>
<text top="633" left="56" width="240" height="9" font="font5" id="p1_t46" reading_order_no="43" segment_no="7" tag_type="text">available at the time of these studies, did not provide a com-</text>
<text top="645" left="56" width="203" height="9" font="font5" id="p1_t47" reading_order_no="44" segment_no="7" tag_type="text">prehensive comparison of all proteins or transcripts.<a href="">r [2],</a> but, due to the limitations of technology</text>
<text top="669" left="56" width="240" height="9" font="font5" id="p1_t48" reading_order_no="45" segment_no="9" tag_type="text">Multiple large-scale analytical techniques now make it possi-</text>
<text top="680" left="56" width="240" height="9" font="font5" id="p1_t49" reading_order_no="46" segment_no="9" tag_type="text">ble to capture entire transcriptomes of defined cell popula-</text>
<text top="692" left="56" width="240" height="9" font="font5" id="p1_t50" reading_order_no="47" segment_no="9" tag_type="text">tions. Breast cancers have been extensively analysed with</text>
<text top="704" left="56" width="240" height="9" font="font5" id="p1_t51" reading_order_no="48" segment_no="9" tag_type="text">both expression arrays [14] and with direct sequencing tech-</text>
<text top="716" left="56" width="240" height="9" font="font5" id="p1_t52" reading_order_no="49" segment_no="9" tag_type="text">niques such as serial analysis of gene expression (SAGE)</text>
<text top="727" left="56" width="240" height="9" font="font5" id="p1_t53" reading_order_no="50" segment_no="9" tag_type="text">[15]. Although several studies have correlated expression data<a href="">arrays [14] an</a>d with direct sequencing tech-</text>
<text top="108" left="315" width="240" height="9" font="font5" id="p1_t54" reading_order_no="51" segment_no="1" tag_type="text">based on microarray and SAGE [16,17], a comprehensive</text>
<text top="120" left="315" width="241" height="9" font="font5" id="p1_t55" reading_order_no="52" segment_no="1" tag_type="text">genome-wide expression profile using a combination of com-<a href="">[15]</a>. Although several studies have correlated expression data</text>
<text top="132" left="315" width="240" height="9" font="font5" id="p1_t56" reading_order_no="53" segment_no="1" tag_type="text">plementary technologies has not yet been achieved for puri-<a href="">SAGE [16,17]</a>, a comprehensive</text>
<text top="144" left="315" width="240" height="9" font="font5" id="p1_t57" reading_order_no="54" segment_no="1" tag_type="text">fied malignant epithelial breast cells in comparison with</text>
<text top="155" left="315" width="240" height="9" font="font5" id="p1_t58" reading_order_no="55" segment_no="1" tag_type="text">purified normal breast epithelial cells. In this study, massively</text>
<text top="167" left="315" width="240" height="9" font="font5" id="p1_t59" reading_order_no="56" segment_no="1" tag_type="text">parallel signature sequencing (MPSS) [18,19] and multiple</text>
<text top="179" left="315" width="240" height="9" font="font5" id="p1_t60" reading_order_no="57" segment_no="1" tag_type="text">genome-wide microarrays have been used to analyse immu-</text>
<text top="191" left="315" width="240" height="9" font="font5" id="p1_t61" reading_order_no="58" segment_no="1" tag_type="text">nomagnetically separated normal luminal epithelial cells and<a href="">S) [18,19] and </a>multiple</text>
<text top="202" left="315" width="240" height="9" font="font5" id="p1_t62" reading_order_no="59" segment_no="1" tag_type="text">primary breast cancers substantially enriched for the neoplas-</text>
<text top="214" left="315" width="240" height="9" font="font5" id="p1_t63" reading_order_no="60" segment_no="1" tag_type="text">tic epithelial component. The aim of this study was to establish</text>
<text top="226" left="315" width="240" height="9" font="font5" id="p1_t64" reading_order_no="61" segment_no="1" tag_type="text">a virtually complete coverage of transcripts deregulated in the</text>
<text top="238" left="315" width="240" height="9" font="font5" id="p1_t65" reading_order_no="62" segment_no="1" tag_type="text">neoplastic cells of human breast cancer. In addition, expres-</text>
<text top="249" left="315" width="240" height="9" font="font5" id="p1_t66" reading_order_no="63" segment_no="1" tag_type="text">sion profiles from normal luminal and myoepithelial cells have</text>
<text top="261" left="315" width="240" height="9" font="font5" id="p1_t67" reading_order_no="64" segment_no="1" tag_type="text">been used to identify cell-type specific transcripts and onto-</text>
<text top="273" left="315" width="240" height="9" font="font5" id="p1_t68" reading_order_no="65" segment_no="1" tag_type="text">logically related gene sets in the differentially expressed</text>
<text top="285" left="315" width="240" height="9" font="font5" id="p1_t69" reading_order_no="66" segment_no="1" tag_type="text">tumour epithelial transcriptome. The use of highly enriched cell</text>
<text top="296" left="315" width="240" height="9" font="font5" id="p1_t70" reading_order_no="67" segment_no="1" tag_type="text">preparations in combination with a multiplatform approach to</text>
<text top="308" left="315" width="240" height="9" font="font5" id="p1_t71" reading_order_no="68" segment_no="1" tag_type="text">their expression analysis has revealed novel markers and</text>
<text top="320" left="315" width="240" height="9" font="font5" id="p1_t72" reading_order_no="69" segment_no="1" tag_type="text">potential targets, the clinical significance of some of which has</text>
<text top="332" left="315" width="179" height="9" font="font5" id="p1_t73" reading_order_no="70" segment_no="1" tag_type="text">also been examined, using tissue microarrays.</text>
<text top="355" left="315" width="121" height="10" font="font4" id="p1_t74" reading_order_no="71" segment_no="4" tag_type="title">Materials and methods</text>
<text top="367" left="315" width="85" height="8" font="font6" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="title">Sample preparation</text>
<text top="378" left="315" width="241" height="10" font="font5" id="p1_t76" reading_order_no="73" segment_no="6" tag_type="text">Ten primary cultures (approximately 10 7 ) of normal human<b>Materials and methods</b></text>
<text top="390" left="315" width="240" height="9" font="font5" id="p1_t77" reading_order_no="74" segment_no="6" tag_type="text">breast luminal and myoepithelial cells were prepared from<b>Sample preparation</b></text>
<text top="402" left="315" width="240" height="9" font="font5" id="p1_t78" reading_order_no="75" segment_no="6" tag_type="text">reduction mammoplasty samples by double immunomagnetic</text>
<text top="414" left="315" width="240" height="9" font="font5" id="p1_t79" reading_order_no="76" segment_no="6" tag_type="text">sorting methods [7,8,10]. In brief, breast epithelial cells were</text>
<text top="426" left="315" width="240" height="9" font="font5" id="p1_t80" reading_order_no="77" segment_no="6" tag_type="text">immunomagnetically purified using combined positive mag-</text>
<text top="437" left="315" width="240" height="9" font="font5" id="p1_t81" reading_order_no="78" segment_no="6" tag_type="text">netic activated cell sorting (MACS; Miltenyi Biotec, Auburn,</text>
<text top="449" left="315" width="240" height="9" font="font5" id="p1_t82" reading_order_no="79" segment_no="6" tag_type="text">CA) selection with antibodies against the luminal epithelial</text>
<text top="461" left="315" width="240" height="9" font="font5" id="p1_t83" reading_order_no="80" segment_no="6" tag_type="text">marker EMA (rat monoclonal ICR-2, Seralab, Leicestershire,<a href="">[7,8,10]. In</a> brief, breast epithelial cells were</text>
<text top="473" left="315" width="240" height="9" font="font5" id="p1_t84" reading_order_no="81" segment_no="6" tag_type="text">UK) and the myoepithelial membrane antigen CD10 (mouse</text>
<text top="484" left="315" width="240" height="9" font="font5" id="p1_t85" reading_order_no="82" segment_no="6" tag_type="text">monoclonal CALLA clone SS2/36, DAKO Corporation, Glos-</text>
<text top="496" left="315" width="240" height="9" font="font5" id="p1_t86" reading_order_no="83" segment_no="6" tag_type="text">trup, Denmark), followed by negative Dynabead (Dynal, UK)</text>
<text top="505" left="315" width="240" height="12" font="font5" id="p1_t87" reading_order_no="84" segment_no="6" tag_type="text">selection using mouse monoclonal antibodies against anti- Î² -</text>
<text top="520" left="315" width="240" height="9" font="font5" id="p1_t88" reading_order_no="85" segment_no="6" tag_type="text">4-integrin clone A9, a myoepithelial cell-surface antigen</text>
<text top="531" left="315" width="240" height="9" font="font5" id="p1_t89" reading_order_no="86" segment_no="6" tag_type="text">(Santa Cruz Biotechnology, CA, USA) and BerEp-4 Epithelial</text>
<text top="543" left="315" width="240" height="9" font="font5" id="p1_t90" reading_order_no="87" segment_no="6" tag_type="text">Antigen, a luminal antigen (DAKO Corporation, Glostrup, Den-</text>
<text top="555" left="315" width="240" height="9" font="font5" id="p1_t91" reading_order_no="88" segment_no="6" tag_type="text">mark). Immunostaining with myoepithelial and luminal-specific</text>
<text top="567" left="315" width="240" height="9" font="font5" id="p1_t92" reading_order_no="89" segment_no="6" tag_type="text">lineage markers showed the final sort of epithelial cells used in</text>
<text top="578" left="315" width="240" height="9" font="font5" id="p1_t93" reading_order_no="90" segment_no="6" tag_type="text">this study to be &gt;95% pure. Full details of these procedures</text>
<text top="590" left="315" width="240" height="9" font="font5" id="p1_t94" reading_order_no="91" segment_no="6" tag_type="text">are not only contained in previous publications [10,11], but are</text>
<text top="602" left="315" width="240" height="9" font="font5" id="p1_t95" reading_order_no="92" segment_no="6" tag_type="text">also appended, as required, to the Minimum information about</text>
<text top="614" left="315" width="240" height="9" font="font5" id="p1_t96" reading_order_no="93" segment_no="6" tag_type="text">a microarray experiment (MIAME) protocol that accompanies</text>
<text top="625" left="315" width="114" height="9" font="font5" id="p1_t97" reading_order_no="94" segment_no="6" tag_type="text">submission E-TABM-66 [20].</text>
<text top="649" left="315" width="240" height="9" font="font5" id="p1_t98" reading_order_no="95" segment_no="8" tag_type="text">Malignant breast epithelial cells of 50 freshly isolated primary</text>
<text top="661" left="315" width="240" height="9" font="font5" id="p1_t99" reading_order_no="96" segment_no="8" tag_type="text">infiltrating ductal carcinomas of histological grade 2 and 3</text>
<text top="672" left="315" width="240" height="9" font="font5" id="p1_t100" reading_order_no="97" segment_no="8" tag_type="text">were enriched from disaggregated tumour tissue as described<a href="">ions [10,11], </a>but are</text>
<text top="684" left="315" width="240" height="9" font="font5" id="p1_t101" reading_order_no="98" segment_no="8" tag_type="text">previously [9]. In brief, fresh tumour biopsies (1 to 2 g) were</text>
<text top="696" left="315" width="240" height="9" font="font5" id="p1_t102" reading_order_no="99" segment_no="8" tag_type="text">comminuted to approximately 1 mm 3 , using scalpel blades,</text>
<text top="708" left="315" width="241" height="9" font="font5" id="p1_t103" reading_order_no="100" segment_no="8" tag_type="text">and subjected to a controlled disaggregation using 0.25%<a href="">sion E-TABM-66 [20].</a></text>
<text top="719" left="315" width="240" height="9" font="font5" id="p1_t104" reading_order_no="101" segment_no="8" tag_type="text">collagenase Type1 (Sigma-Aldrich, Dorset, UK) in L-15</text>
</page>
</pdf2xml>
